PTX 2.44% 4.2¢ prescient therapeutics limited

Ann: Prescient to resume AML trial, page-2

  1. 553 Posts.
    "clinicians involved remain engaged and are enthusiastic to recommence recruitment for this exciting AML study".  Back to the start or can they still use some of the data gathered prior to the suspension?
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.